SUNLENCA 464mg solution for injection GILEAD ORIGINAL MEDICINE
Chemical substance: lenacapavir
ATC code: J05AX31 • Antiinfectives for systemic use | Direct acting antivirals | Other antivirals
Active substance
Results for the substance lenacapavir
2 results
About this active substance
Lenacapavir is an antiretroviral medication used for the treatment of HIV-1 infection. It acts as a capsid inhibitor, interfering with multiple stages of the viral replication cycle.
The medication is administered as a subcutaneous injection, usually once every six months, under the supervision of a specialist. It is used in combination with other antiretroviral drugs to enhance treatment efficacy.
Side effects may include injection site reactions, nausea, fatigue, or headaches. In rare cases, severe allergic reactions may occur.
Lenacapavir is not recommended for patients with hypersensitivity to this medication or those taking drugs that interact with capsid metabolism.
The medication is administered as a subcutaneous injection, usually once every six months, under the supervision of a specialist. It is used in combination with other antiretroviral drugs to enhance treatment efficacy.
Side effects may include injection site reactions, nausea, fatigue, or headaches. In rare cases, severe allergic reactions may occur.
Lenacapavir is not recommended for patients with hypersensitivity to this medication or those taking drugs that interact with capsid metabolism.
-
-
SUNLENCA 300mg film-coated tablets GILEAD ORIGINAL MEDICINE
Chemical substance: lenacapavir
ATC code: J05AX31 • Antiinfectives for systemic use | Direct acting antivirals | Other antivirals